{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:43:34Z","timestamp":1792190614233,"version":"4.4.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"suppl 1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T00:00:00Z","timestamp":1444694400000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Med"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1111\/pme.12926","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:37:37Z","timestamp":1444783057000},"page":"S9-S15","source":"Crossref","is-referenced-by-count":61,"title":["Opioid Related Endocrinopathy: Table 1"],"prefix":"10.1093","volume":"16","author":[{"given":"Jeffrey A.","family":"Gudin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Laitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Nalamachu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,10,1]]},"reference":[{"key":"2016010323564392000_16.suppl_1.S9.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2014.05.009"},{"key":"2016010323564392000_16.suppl_1.S9.2","unstructured":"Institute of Medicine Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: A blueprint for transforming prevention, care, education, and research. Washington, DC: National Academies Press; 2011."},{"key":"2016010323564392000_16.suppl_1.S9.3","unstructured":"National Institute of Health. Prescription Opioid and Heroin Abuse. Available at: http:\/\/www.drugabuse.gov\/about-nida\/legislative-activities\/testimony-to-congress\/2014\/prescription-opioid-heroin-abuse (accessed November 2014)."},{"key":"2016010323564392000_16.suppl_1.S9.4","doi-asserted-by":"crossref","unstructured":"Kumar L Barker C Emmanuel A . Opioid-induced constipation: Pathophysiology, clinical consequences, and management. Gastroenterol Res Pract 2014;1\u20136.","DOI":"10.1155\/2014\/141737"},{"key":"2016010323564392000_16.suppl_1.S9.5","doi-asserted-by":"publisher","DOI":"10.1038\/srep06189"},{"key":"2016010323564392000_16.suppl_1.S9.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.12.001"},{"key":"2016010323564392000_16.suppl_1.S9.7","unstructured":"Tennant F . Testosterone replacement: Essential in pain management. Practical Pain Management. 2010. Available at: http:\/\/www.practicalpainmanagement.com\/treatments\/hormone-therapy\/testosterone-replacement-essential-pain-management?page=0,2 (accessed July 2015)."},{"key":"2016010323564392000_16.suppl_1.S9.8","doi-asserted-by":"publisher","DOI":"10.1126\/science.3975627"},{"key":"2016010323564392000_16.suppl_1.S9.9","doi-asserted-by":"crossref","unstructured":"Stoffel EC Ulibarri CM Folk JE Rice KC Craft RM . Gonadal hormone modulation of mu, kappia, and, delta opioid antinociception in male and female rats. J Pain 2006;6:261\u201374.","DOI":"10.1016\/j.jpain.2004.12.006"},{"key":"2016010323564392000_16.suppl_1.S9.10","unstructured":"Miner MM . Low Testosterone Medscape CME Expert Column Series. Issue 2: Screening and Workup for Testosterone Deficiency. Medscape 2011; Available at: http:\/\/www.medscape.rog\/viewarticle\/749240 (accessed July 2015)."},{"key":"2016010323564392000_16.suppl_1.S9.11","unstructured":"Demling RH . The role of anabolic hormones for wound healing in catabolic states. J Burns Wounds 2005;4:46\u201362."},{"key":"2016010323564392000_16.suppl_1.S9.12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20028"},{"key":"2016010323564392000_16.suppl_1.S9.13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.6.2215"},{"key":"2016010323564392000_16.suppl_1.S9.14","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e31827c7b5d"},{"key":"2016010323564392000_16.suppl_1.S9.15","doi-asserted-by":"crossref","unstructured":"Elliott JA Horton E Fibuch EE . The endocrine effects of long-term oral opioid therapy: A case report and review of the literature. J Opioid Manag 2011;7:145\u201354.","DOI":"10.5055\/jom.2011.0057"},{"key":"2016010323564392000_16.suppl_1.S9.16","unstructured":"Coren JS . Opioid-induced endocrinopathy. J AM Osteopath Assoc 2009;109:20\u20135."},{"key":"2016010323564392000_16.suppl_1.S9.17","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-7-25"},{"key":"2016010323564392000_16.suppl_1.S9.18","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-6-69"},{"key":"2016010323564392000_16.suppl_1.S9.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2009.05.013"},{"key":"2016010323564392000_16.suppl_1.S9.20","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200205000-00002"},{"key":"2016010323564392000_16.suppl_1.S9.21","doi-asserted-by":"publisher","DOI":"10.1159\/000123558"},{"key":"2016010323564392000_16.suppl_1.S9.22","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181d1059d"},{"key":"2016010323564392000_16.suppl_1.S9.23","doi-asserted-by":"publisher","DOI":"10.2174\/138161212803582414"},{"key":"2016010323564392000_16.suppl_1.S9.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2012.01368.x"},{"key":"2016010323564392000_16.suppl_1.S9.25","doi-asserted-by":"crossref","unstructured":"Daniell HW . Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain 2008;9:28\u201336.","DOI":"10.1016\/j.jpain.2007.08.005"},{"key":"2016010323564392000_16.suppl_1.S9.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2006.04.011"},{"key":"2016010323564392000_16.suppl_1.S9.27","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.137.7.862"},{"key":"2016010323564392000_16.suppl_1.S9.28","doi-asserted-by":"crossref","unstructured":"Smith HS Elliott JA . Opioid-induced androgen deficiency (OPIAD). Pain Phys 2012;15:ES145\u201356.","DOI":"10.36076\/ppj.2012\/15\/ES145"},{"key":"2016010323564392000_16.suppl_1.S9.29","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181850df6"},{"key":"2016010323564392000_16.suppl_1.S9.30","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-56-6-1278"},{"key":"2016010323564392000_16.suppl_1.S9.31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.2.561"},{"key":"2016010323564392000_16.suppl_1.S9.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(01)00782-6"},{"key":"2016010323564392000_16.suppl_1.S9.33","doi-asserted-by":"publisher","DOI":"10.1097\/01.j.pain.0000460308.86819.aa"},{"key":"2016010323564392000_16.suppl_1.S9.34","unstructured":"Goswami A . Ask the expert: Should you test for and treat opioid-induced Hypogonadism? Practical Pain Management. 2013. Available at: http:\/\/www.practicalpainmanagement.com\/treatments\/pharmacological\/opioids\/ask-expert-should-you-test-treat-opioid-induced-hypogonadism (accessed July 2014)."},{"key":"2016010323564392000_16.suppl_1.S9.35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2354"},{"key":"2016010323564392000_16.suppl_1.S9.36","doi-asserted-by":"crossref","unstructured":"American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Menopause: Androgen deficiency in postmenopausal women. 2006. Available at: www.medscape.com\/viewarticle\/540531_12 (accessed August 2010). Also available at: Endocr Pract. 2006;12(3):315\u2013337.","DOI":"10.4158\/EP.12.3.315"},{"key":"2016010323564392000_16.suppl_1.S9.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02355.x"},{"key":"2016010323564392000_16.suppl_1.S9.38","unstructured":"FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm436259.htm (accessed July 2015)."},{"key":"2016010323564392000_16.suppl_1.S9.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2006.09.001"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/16\/suppl_1\/S9\/7497745\/16-suppl_1-S9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T04:16:04Z","timestamp":1653279364000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-lookup\/doi\/10.1111\/pme.12926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":39,"journal-issue":{"issue":"suppl 1","published-online":{"date-parts":[[2015,10,1]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1111\/pme.12926"],"URL":"https:\/\/doi.org\/10.1111\/pme.12926","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}